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Pathogens such as Listeria have been used to define host factors regulating actin dynamics, including the
Arp2/3 complex. In this issue of Cell Host & Microbe, Serio et al. (2010) use Rickettsia to identify a new
complex, based on profilin, which regulates actin dynamics in normal cells and which may be exploitable
by diverse pathogens.Bacterial and viral pathogens exploit the
host cytoskeleton to move into, through,
and out of infected cells, and some
pathogens even stimulate the cells they
infect to themselves move. As such,
understanding how pathogens usurp host
cytoskeletal function has proven tremen-
dously valuable for elucidating basic
mechanismsof bothpathogendissemina-
tion and cytoskeletal function. It has long
been recognized that actin monomers
spontaneously polymerize at very low
rates to formfilaments; thus, a ‘‘nucleator’’
composed of a few monomers is required
to initiate polymerization. How does this
happen? Attempts to purify actin poly-
merizing agents yielded numerous actin-
binding proteins but no clear mecha-
nism—that is, until Welch, Mitchison, and
colleagues turned to a pathogen Listeria
monocytogenes, which polymerizes actin
as a means of moving through the cyto-
plasm of an infected cell and burrowing
into an apposing uninfected cell. Using
Listeria motility in a cell-free extract
system as an assay (Theriot et al., 1994),
Welch, Mitchison, and colleagues purified
a complex of seven proteins, called the
Arp2/3 complex, which was required for
not only Listeria motility (Welch et al.,
1997b) but also for actin polymerization
at the leading edge of motile cells (Welch
et al., 1997a). The Arp2/3 complex had
everything required, including two actin-
related proteins that served as nucleators
for nascent filaments. Welch and Mitchi-
sonwent on to demonstrate that the Liste-
ria surface protein ActA was the bacterial
activator of the Arp2/3 complex (Welch
et al., 1998).
But what is the cellular homolog of
ActA? Using a two-hybrid approach,
Machesky and Insall found that the Arp2/3complex bound to SCAR, a mammalian
homolog of an actinmotility protein identi-
fied genetically in the amoeba Dictyoste-
lium discoidium, and WASP (Machesky
and Insall, 1998). Kirschner and col-
leagues, using biochemical approaches,
demonstrated that N-WASP activates
the Arp2/3 complex using a C-terminal
domain that resembled ActA (Rohatgi
et al., 1999). Simultaneously, work with
enteropathogenic Escherichia coli (EPEC)
showed that the C-terminal domain of
N-WASP was required in cells to form
actin-filled membraneous protrusions, or
pedestals, beneath attached bacteria,
and thus might serve as a signaling bridge
between molecules at the plasma
membrane and the actin polymerization
machinery (Kalman et al., 1999). Work
with poxviruses, which form actin protru-
sions upon their emergence at the cell
surface, and Shigella flexneri, which, like
Listeria, move through the cytoplasm,
solidified a role for the N-WASP-Arp2/3
system in pathogen motility.
But there were heretical rumbles as
other actin polymerizing proteins were
identified. Was Arp2/3 the only means to
polymerize actin, and do all pathogens
use Arp2/3 complex for motility? In this
issue of Cell Host & Microbe, Serio et al.
(2010) define factors required for motility
of Rickettsia species. Rickettsia are
Gram-negative intracellular bacteria that
are disseminated by ticks and cause
RockyMountain spotted fever and typhus.
Like Listeria, Rickettsia escape from a
phagosomal compartment into the cyto-
sol, where they use actin to propel them-
selves within and between cells. Although
Rickettsia have a protein called RickA that
can nucleate actin via the Arp2/3 complex
in vitro, not all Rickettsia spp. that moveCell Host & Microbexpress it. The question asked by Serio
et al. was whether some other system
might be at play.
Using an RNAi cytoskeletal sublibrary in
Drosophila S2 cells, Serio et al. identify
four proteins: fimbrin, capping protein
and cofilin, and profilin, but not the Arp2/
3 complex and other proteins utilized by
other pathogens. Moreover, they go on
to define similar roles of these proteins in
mammalian cells. All of these proteins are
known to regulate actin filament dynamics
and organization. Fimbrin crosslinks actin
filaments and forms tight actin bundles,
capping protein caps the barbed ends
of actin filaments, and inhibits polymeriza-
tion and depolymerization, and cofilin
severs and depolymerizes actin filaments.
Indeed, Pollard and Borisy (2003) pro-
posed that profilin, capping protein, and
cofilin regulate Arp2/3-dependent ‘‘den-
dritic actin nucleation’’ in lamellipodial
actin networks and Listeria actin tails.
How might these factors coordinate
actin dynamics in the absence of Arp2/3
complex? The key may be profilin, which
catalyzes exchange of actin-bound ATP/
ADP to produce polymerization-compe-
tent ATP-actin momomers and promotes
elongation from exposed barbed ends
of actin filaments, but not from pointed
ends. Therefore, when barbed ends are
capped by capping protein, profilin se-
questers actin monomers that are only
available for polymerization at new actin
nucleation sites. Serio et al. (2010) pro-
pose that capping protein caps old actin
barbed ends away from the bacterial
surface so that profilin-actin is directed
to polymerize actin and elongate the fila-
ment at the bacterial surface.
Profilin by itself inhibits actin nucleation
and therefore would need to cooperatee 7, May 20, 2010 ª2010 Elsevier Inc. 335
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Previewswith a nucleating factor(s) to promote
actin motility. It is known that profilin and
formins interact in such a manner. Thus,
profilin-actin complexes may bind to the
formin-homology (FH) domain of formin,
which can in turn nucleate actin polymer-
ization and bind to barbed ends proces-
sively as the filaments grow. Formin-profi-
lin complexes can thereby cooperatively
enhance filament elongation at barbed
ends. However, Serio et al. (2010) tested
six Drosophila formins, but none was
required for Rickettsia motility, though
it remains possible that these proteins
play a redundant role. Alternatively, in
a manner analogous to ActA in Listeria,
the bacteria may itself encode a formin-
like protein. In this regard, R. rickettsii
Sca2 is required for motility and virulence
(Kleba et al., 2010); it will be interesting to
see whether the protein encoded by this
gene contains an FH-like domain that
interacts with profilin.336 Cell Host & Microbe 7, May 20, 2010 ª20UsingRickettsia, Serio et al. (2010) have
revealed the function of a set of cytoskel-
etal proteins whose role in actin dynamics
have been suspected but never so clearly
defined. With Rickettsia, it will be inter-
esting to see whether the RickA-Arp2/3
or Sca2-profilin complexes catalyze dis-
tinct actin-dependent processes during
infection. Indeed, it may turn out that
many pathogens use both actin polymer-
ization systems. Such explorations may,
in turn, elucidate novel regulatory sig-
naling mechanisms as well as an under-
standing of how normal cells control actin
dynamics.
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Viral infection leads to the rapid production of type I interferons within infected tissues. In this issue of Cell
Host &Microbe, Hermesh et al. (2010) demonstrate that interferons produced following respiratory viral infec-
tion program leukocytes in the bone marrow to resist infection before trafficking to the lung.Immune responses to viral infection of the
respiratory tract are triggered by the
innate recognition of pathogen-associ-
ated molecular patterns. One of the
earliest antiviral responses is the
synthesis of type I interferons (IFNs),
which can signal back to the infected
cell, as well as to surrounding cells,
through the ubiquitously expressed
IFNa/b receptor. Signaling through the
IFNa/b receptor initiates a positive feed-
back loop, resulting in enhanced IFN
production, the expression of genes that
inhibit viral replication, and the amplifica-
tion of the antiviral response (Moltedoet al., 2009). Concomitantly, a robust
inflammatory response, including the
production of cytokines and chemokines,
serves to recruit leukocytes to the lung.
Hermesh and colleagues now show that
type I IFNs produced in the lung can
interact directly with leukocytes residing
in the bone marrow, activating antiviral
transcription programs that protect these
cells from infection with a wide range of
viruses (Hermesh et al., 2010). Taken in
broader context, these findings demon-
strate that peripheral infections can
‘‘communicate’’ with leukocytes in the
bone marrow, priming these cells to resistinfection prior to their arrival in infected
tissues, thus promoting their survival and
assuring their ability to carry out antiviral
functions (Figure 1).
The ability of type I IFNs to induce anti-
viral gene expression and inhibit viral
replication within infected tissues has
been well described (Katze et al., 2002).
However, previous models for the effect
of type I INFs on migrating leukocytes
during peripheral infections assumed
that IFNa/b receptor signaling, and
expression of IFN-inducible genes,
occurred once leukocytes migrated to in-
fected tissues. Hermesh et al. (2010) used
